Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endpoints in Heart Failure Drug Development: History and Future.
Fiuzat M, Lowy N, Stockbridge N, Sbolli M, Latta F, Lindenfeld J, Lewis EF, Abraham WT, Teerlink J, Walsh M, Heidenreich P, Bozkurt B, Starling RC, Solomon S, Felker GM, Butler J, Yancy C, Stevenson LW, O'Connor C, Unger E, Temple R, McMurray J. Fiuzat M, et al. Among authors: temple r. JACC Heart Fail. 2020 Jun;8(6):429-440. doi: 10.1016/j.jchf.2019.12.011. Epub 2020 Apr 8. JACC Heart Fail. 2020. PMID: 32278679 Free article. Review.
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy.
Sanders GD, Al-Khatib SM, Berliner E, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis AB, Curtis JP, Domanski M, Fain E, Gersh BJ, Gold MR, Goldberger J, Haghighi-Mood A, Hammill SC, Harder J, Healey J, Hlatky MA, Hohnloser SH, Lee KL, Mark DB, Mitchell B, Phurrough S, Prystowsky E, Smith JM, Stockbridge N, Temple R; Expert panel participating in a Duke Center for the Prevention of Sudden Cardiac Death-sponsored conference. Sanders GD, et al. Among authors: temple r. Am Heart J. 2007 Jun;153(6):951-9. doi: 10.1016/j.ahj.2007.03.002. Am Heart J. 2007. PMID: 17540195
Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005.
Jackson K, Gersh BJ, Stockbridge N, Fleming TR, Temple R, Califf RM, Connolly SJ, Wallentin L, Granger CB; Duke Clinical Research Institute/American Heart Journal Expert Meeting on Antithrombotic Drug Development for Atrial Fibrillation. Jackson K, et al. Among authors: temple r. Am Heart J. 2008 May;155(5):829-40. doi: 10.1016/j.ahj.2008.01.023. Am Heart J. 2008. PMID: 18440329 Review.
Erythropoiesis-stimulating agents--time for a reevaluation.
Unger EF, Thompson AM, Blank MJ, Temple R. Unger EF, et al. Among authors: temple r. N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6. N Engl J Med. 2010. PMID: 20054037 No abstract available.
Removal from labeling of 60-mg citalopram dose.
Temple R, Laughren T, Stockbridge N. Temple R, et al. Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):784-786. doi: 10.1002/pds.3289. Pharmacoepidemiol Drug Saf. 2012. PMID: 22761131 No abstract available.
Zolpidem and driving impairment--identifying persons at risk.
Farkas RH, Unger EF, Temple R. Farkas RH, et al. Among authors: temple r. N Engl J Med. 2013 Aug 22;369(8):689-91. doi: 10.1056/NEJMp1307972. Epub 2013 Aug 7. N Engl J Med. 2013. PMID: 23923991 Free article. No abstract available.
329 results